PuSH - Publication Server of Helmholtz Zentrum München

216 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Stewart, C.J.* et al.: Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583-588 (2018)
42.
Uusitalo, U.* et al.: Early infant diet and islet autoimmunity in the TEDDY Study. Diabetes Care 41, 522-530 (2018)
43.
Vatanen, T.* et al.: The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589-594 (2018)
44.
Winkler, C. & Ziegler, A.-G.: Neue Studie zur Prävention von Typ-1-Diabetes. Diabetes akt. 16, 52-54 (2018)
45.
Ziegler, A.-G. et al.: Früherkennung und Primärprävention des Typ-1-Diabetes: „Global Platform for the Prevention of Autoimmune Diabetes“ (GPPAD). Diabetologe 14, 240-244 (2018)
46.
Beyerlein, A. ; Wehweck, F. ; Ziegler, A.-G. & Pflüger, M.: Miscalculation and errors in numbers reported in table. JAMA Pediatr. 171, 93 (2017)
47.
Beyerlein, A. et al.: Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data. Vaccine 35, 1735-1741 (2017)
48.
TEDDY Study Group (Beyerlein, A. ; Winkler, C. ; Ziegler, A.-G. ; Hummel, S.) et al.: Intake of energy and protein is associated with overweight risk at age 5.5 years: Results from the prospective TEDDY study. Obesity 25, 1435-1441 (2017)
49.
Beyerlein, A. ; Donnachie, E.* & Ziegler, A.-G.: Infections in early Life and development of celiac disease. Am. J. Epidemiol. 186, 1277-1280 (2017)
50.
Bonifacio, E.* et al.: Rebranding asymptomatic type 1 diabetes: The case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 60, 35-38 (2017)
51.
Dandona, P.* et al.: Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial. Lancet Diabet. Endocrinol. 5, 864-876 (2017)
52.
Elding Larsson, H.* et al.: Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61, 193–202 (2017)
53.
Fuchs, Y.F. et al.: CD8+ T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage. Sci. Rep. 7:44661 (2017)
54.
Hagopian, W.* et al.: Co-occurrence of type 1 diabetes and celiac disease autoimmunity. Pediatrics 140, DOI: 10.1542/peds.2017-1305 (2017)
55.
Heninger, A.K.* et al.: A divergent population of autoantigen-responsive CD4+ T cells in infants prior to β cell autoimmunity. Sci. Transl. Med. 9:eaaf8848 (2017)
56.
Hommel, A.* et al.: Screening for type 1 diabetes risk in newborns: The Freder1k pilot study in Saxony. Horm. Metab. Res. 50, 44-49 (2017)
57.
TEDDY Study Group (Hummel, S. ; Beyerlein, A. ; Ziegler, A.-G.) et al.: First infant formula type and risk of islet autoimmunity in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 40, 398-404 (2017)
58.
Kälin, S. et al.: A Stat6/Pten axis links regulatory T cells with adipose tissue function. Cell Metab. 26, 475-492.e7 (2017)
59.
Kemppainen, K.M.* et al.: Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin. Gastroenterol. Hepatol. 15, 694-702 (2017)
60.
Kemppainen, K.M.* et al.: Association between early-life antibiotic use and the risk of islet or celiac disease autoimmunity. JAMA Pediatr. 171, 1217-1225 (2017)